CXC-chemokine stimulation of neutrophils correlates with plasma levels of myeloperoxidase and lactoferrin and contributes to clinical outcome after pediatric cardiac surgery

Shock

Volumn 22, Issue 6, 2004, Pages 513-520

  Gessler, Peter ^a   Pretre, Rene ^b   Hohl, Viviane ^a   Rousson, Valentin ^c   Fischer, Joachim ^d   Dahinden, Clemens ^e  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d ETH ZURICH   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cardiopulmonary bypass; Chemokine receptors; Congenital heart defects; Inflammation; Neutrophil activation

Indexed keywords

ALPHA CHEMOKINE; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; INTERLEUKIN 8; LACTOFERRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE;

ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR FUNCTION; CELL STIMULATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; IN VIVO STUDY; INFANT; INFLAMMATION; INOTROPISM; LEUKOCYTE ACTIVATION; NEUTROPHIL; OPEN HEART SURGERY; PATHOPHYSIOLOGY; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN SECRETION; TREATMENT OUTCOME;

CHEMOKINE CCL2; CHEMOKINES, CXC; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INTERLEUKIN-8; LACTIC ACID; LACTOFERRIN; NEUTROPHILS; PEROXIDASE; POSTOPERATIVE CARE; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; THORACIC SURGERY; TREATMENT OUTCOME;

EID: 9644266854     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000145939.54838.51     Document Type: Article

References (40)

1. Laffey JG, Boylan JF, Cheng DCH: The systemic inflammatory response to cardiac surgery. Anesthesiology 97:215-252, 2002.
2. Tarnok A, Schneider P: Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock 16:24-32, 2001.
3. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 320:365-376, 1989.
4. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389, 1992.
5. Partrick DA, Moore EE, Fullerton DA, Barnett CC Jr, Meldrum DR, Silliman CC: Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res 86:42-49, 1999.
6. Shames BD, Zallen GS, McIntyre RC Jr, Bensard DD, Pulido EJ, Miller SA, Pomerantz BJ, Selzman CH, Meng X, Harken AH: Chemokines as mediators of diseases related to surgical conditions. Shock 14:1-7, 2000.
7. Luster AD: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445, 1998.
8. Baggiolini M: Chemokines and leukocyte traffic. Nature 392:565-568, 1998.
9. i signaling in biologic environments. Shock 10:324-328, 1998.
10. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 253:1278-1280, 1991.
11. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280-1283, 1991.
12. Moser B, Barella L, Mattei S, Schumacher C, Boulay F, Colombo MP, Baggiolini M: Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 294:285-292, 1993.
13. Dunican AL, Leuenroth SJ, Ayala A, Simms HH: CXC chemokine suppression of polymorphonuclear leukocytes apoptosis and preservation of function is oxidative stress independent. Shock 13:244-250, 2000.
14. Rollins BJ: Chemokines. Blood 90:909-928, 1997.
15. Sasayama S, Okada M, Matsumori A: Chemokines and cardiovascular diseases. Cardiovasc Res 45:267-269, 2000.
16. Gerard C, Rollins BJ: Chemokines and disease. Nature Immunol 2:108-115, 2001.
17. Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, Hughes BJ, Youker KA, Hawkins HK, Michael LH: Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95:89-103, 1995.
18. Ono K, Matsumori A, Furukawa Y, Igata H, Shioi T, Matsushima K, Sasayama S: Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest 79:195-203, 1999.
19. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, MacKay CR, LaRosa GJ, Rossen RD, Smith CW, Entman ML: Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95:693-700, 1997.
20. Kalfin RE, Engelman RM, Rousou JA, Flack JE, Deaton DW, Kreutzer DL, Das DK: Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation 88:401-406, 1993.
21. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 108:636-641, 1994.
22. Gessler P, Pfenninger J, Pfammatter JP, Carrel T, Baenziger O, Dahinden C: Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 126:718-725, 2003.
23. +-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling. Blood 95:1551-1559, 2000.
24. Wolf M, Delgado MB, Jones SA, Dewald B, Clark-Lewis I, Baggiolini M: Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur J Immunol 28:164-170, 1998.
25. Samanta AK, Oppenheim JJ, Matsushima K: Interleukin-8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 265:183-189, 1990.
26. Chuntharapai A, Kim KJ: Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 155:2587-2594, 1995.
27. Wuyts A, Proost P, Lenaerts JP, Ben-Baruch A, Van Damme J, Wang JM: Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem 255:67-73, 1998.
28. Chishti AD, Dark JH, Kesteven P, Powell H, Snowden C, Shenton BK, Kirby JA, Baudouin SV: Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass. J Thorac Cardiovasc Surg 122:1162-1166, 2001.
29. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M: Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acatl Sci USA 93:6682-6686, 1996.
30. Peveri P, Walz A, Dewald B, Baggioloni M: A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 167:1547-1559, 1988.
31. Gessler P, Pfenninger J, Pfammatter JP, Carrel T, Dahinden C: Inflammatory response of neutrophil granulocytes and monocytes after cardiopulmonary bypass in pediatric cardiac surgery. Intensive Care Med 28:1786-1791, 2002.
32. Kawahito K, Kawakami M, Fujiwara T, Adachi H, Ino T: Interleukin-8 and monocyte chemotactic factor responses to cardiopulmonary bypass. J Thorac Cardiovasc Surg 110:99-102, 1995.
33. Lotan D, Zilberman D, Dagan O, Keller N, Ben-Abraham R, Weinbroum AA, Harel R, Barzilay Z, Paret G: Beta-chemokine secretion patterns in relation to clinical course and outcome in children after cardiopulmonary bypass: Continuing the search to abrogate systemic inflammatory response. Ann Thorac Surg 71:233-237, 2001.
34. Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 148:2423-2428, 1992.
35. Karakurum M, Shreeniwas R, Chen J, Pinsky D, Van SD, Anderson M, Sunouchi K, Major J, Hamilton T, Kuwabara K, Rot A, Nowygrod R, Stern D: Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 93:1564-1570, 1994.
36. Metinko AP, Kunkel SL, Standiford TJ, Strieter RM: Anoxia-hyperoxia induces monocyte-derived interleukin-8. J Clin Invest 90:791-798, 1992.
37. Bates JJ, Watson RW, Glynn CM, O'Neill AJ, Fitzpatrick JM, Buggy DJ: Aspirin preserves neutrophil apoptosis after cardiopulmonary bypass. Shock 21:495-499, 2004.
38. Schwarz MK, Wells TNC: New therapeutics that modulate chemokine networks. Nature Rev 1:347-358, 2002.
39. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM: Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8 induced neutrophil migration. J Biol Chem 273:10095-10098, 1998.
40. Jones SA, Dewald B, Clark-Lewis I, Baggiolini M: Chemokine antagonists that discriminate between interleukin-8 receptors. J Biol Chem 272:16166-16169, 1997.